Sectral and Levemir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sectral (acebutolol hydrochloride) and Levemir (insulin detemir recombinant). Common drug interactions include failure to thrive among females and haematoma among males.

The phase IV clinical study analyzes what interactions people have when they take Sectral and Levemir. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Sectral?

Sectral has active ingredients of acebutolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 3,548 Sectral users. Check the latest studies of Sectral.

What is Levemir?

Levemir has active ingredients of insulin detemir recombinant. It is often used in diabetes. eHealthMe is studying from 13,850 Levemir users. Check the latest studies of Levemir.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

18 people who take Sectral and Levemir together, and have interactions are studied.

Sectral and Levemir drug interactions.

What are the common drug interactions of Sectral and Levemir, by gender? *:

female:

  1. Failure to thrive (inadequate weight gain and physical growth in children)
  2. Hypokalaemia (low potassium)
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  4. Limb injury
  5. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  6. Hypoglycaemia neonatal (deficiency of glucose in the bloodstream in neonatal)
  7. Aplasia (defective development or congenital absence of an organ or tissue)
  8. Death
  9. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  10. Lung disorder (lung disease)

male:

  1. Haematoma (collection of blood outside the blood vessels)
  2. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  3. Generalised erythema (redness of the skin all over the body)
  4. Hypocapnia (level of carbon dioxide in the blood is lower than normal)
  5. Hypoxia (low oxygen in tissues)
  6. Interstitial lung disease
  7. Lung disorder (lung disease)
  8. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Pleural disorder

What are the common drug interactions of Sectral and Levemir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  2. Hypotension (abnormally low blood pressure)
  3. Death
  4. Feeling cold
  5. Generalised erythema (redness of the skin all over the body)
  6. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  7. Oedema peripheral (superficial swelling)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Renal impairment (severely reduced kidney function)
  10. Thrombocytopenia (decrease of platelets in blood)

60+:

  1. Haematoma (collection of blood outside the blood vessels)
  2. Failure to thrive (inadequate weight gain and physical growth in children)
  3. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  4. Fatigue (feeling of tiredness)
  5. Fibrin d dimer increased
  6. Hypocapnia (level of carbon dioxide in the blood is lower than normal)
  7. Hypoxia (low oxygen in tissues)
  8. Interstitial lung disease
  9. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

  1. Stable Angina (a constant chest pain): 6 people, 33.33%
  2. Cardiac Failure: 6 people, 33.33%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 33.33%
  4. Hypokalemia (low potassium): 5 people, 27.78%
  5. Lung Neoplasm Malignant (cancer tumour of lung): 5 people, 27.78%
  6. Depression: 3 people, 16.67%
  7. Type 1 Diabetes: 3 people, 16.67%
  8. Type 2 Diabetes: 2 people, 11.11%
  9. Oedema Peripheral (superficial swelling): 2 people, 11.11%
  10. Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Sectral and Levemir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sectral and Levemir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sectral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levemir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sectral and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levemir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acebutolol hydrochloride and insulin detemir recombinant (the active ingredients of Sectral and Levemir, respectively), and Sectral and Levemir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: